TR200200313T2 - Hızla çözünen dozaj formu ve bunun yapım prosesi. - Google Patents

Hızla çözünen dozaj formu ve bunun yapım prosesi.

Info

Publication number
TR200200313T2
TR200200313T2 TR2002/00313T TR200200313T TR200200313T2 TR 200200313 T2 TR200200313 T2 TR 200200313T2 TR 2002/00313 T TR2002/00313 T TR 2002/00313T TR 200200313 T TR200200313 T TR 200200313T TR 200200313 T2 TR200200313 T2 TR 200200313T2
Authority
TR
Turkey
Prior art keywords
dosage form
production process
rapidly dissolving
dissolving dosage
dosage forms
Prior art date
Application number
TR2002/00313T
Other languages
English (en)
Turkish (tr)
Inventor
Martani Rose
Original Assignee
Novartis Consumer Health S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Consumer Health S.A. filed Critical Novartis Consumer Health S.A.
Publication of TR200200313T2 publication Critical patent/TR200200313T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/00313T 1999-08-17 2000-08-14 Hızla çözünen dozaj formu ve bunun yapım prosesi. TR200200313T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99810738 1999-08-17

Publications (1)

Publication Number Publication Date
TR200200313T2 true TR200200313T2 (tr) 2002-04-22

Family

ID=8242980

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00313T TR200200313T2 (tr) 1999-08-17 2000-08-14 Hızla çözünen dozaj formu ve bunun yapım prosesi.

Country Status (8)

Country Link
US (1) US7182959B2 (https=)
EP (1) EP1202716A1 (https=)
JP (1) JP2003506480A (https=)
AU (1) AU765526B2 (https=)
CA (1) CA2380449A1 (https=)
HK (1) HK1046236A1 (https=)
TR (1) TR200200313T2 (https=)
WO (1) WO2001012161A1 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060073188A1 (en) * 1999-03-31 2006-04-06 Pierre Fabre Medicament Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AR034813A1 (es) * 2001-07-20 2004-03-17 Novartis Ag Composiciones farmaceuticas y uso de las mismas
EP1414408B1 (en) * 2001-08-09 2006-03-29 Smithkline Beecham Plc Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
AU2003211051A1 (en) 2002-02-13 2003-09-04 Michael K. Weibel Drug dose-form and method of manufacture
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
JP4320217B2 (ja) * 2002-07-10 2009-08-26 剤盛堂薬品株式会社 鼻炎用経口製剤
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
WO2004098571A1 (en) * 2003-04-30 2004-11-18 Zicam, Llc Cold remedy composition comprising zinc salts
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US20050214365A1 (en) * 2004-03-24 2005-09-29 Gulf Pharmaceutical Industries [Instant dissolving tablet composition for loratidine and desloratidine]
TWI428271B (zh) * 2004-06-09 2014-03-01 Smithkline Beecham Corp 生產藥物之裝置及方法
US20060002594A1 (en) * 2004-06-09 2006-01-05 Clarke Allan J Method for producing a pharmaceutical product
US8101244B2 (en) * 2004-06-09 2012-01-24 Smithkline Beecham Corporation Apparatus and method for producing or processing a product or sample
AR051397A1 (es) 2004-10-21 2007-01-10 Novartis Ag Composicion farmaceutica
KR101379297B1 (ko) * 2004-10-28 2014-04-10 팬택 아게 고 다공성, 속해성 고형 투여 형태 및 분말 제조 및동결건조 단계를 포함하는 그의 제조 방법
AU2007338751A1 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets containing a high dose of pharmaceutically active ingredients
EP2170282A4 (en) * 2007-06-27 2014-11-05 Hanmi Pharm Ind Co Ltd METHOD FOR PRODUCING A QUICKLY CRUSHING FORMULATION FOR ORAL ADMINISTRATION AND DEVICE FOR PREPARING AND PACKAGING THE FORMULATION
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
US9968564B2 (en) * 2009-06-05 2018-05-15 Intercontinental Great Brands Llc Delivery of functional compounds
US20100310726A1 (en) 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Novel Preparation of an Enteric Release System
US20100307542A1 (en) * 2009-06-05 2010-12-09 Kraft Foods Global Brands Llc Method of Reducing Surface Oil on Encapsulated Material
US8859003B2 (en) * 2009-06-05 2014-10-14 Intercontinental Great Brands Llc Preparation of an enteric release system
AU2010284028A1 (en) * 2009-08-17 2012-03-29 Waxtabs (Pty) Ltd Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith
US20110105441A1 (en) * 2009-10-30 2011-05-05 Fmc Corporation Stable Orally Disintegrating Tablets Having Low Superdisintegrant
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
DK2493457T3 (en) 2009-10-30 2017-10-02 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US20110150993A1 (en) * 2009-12-22 2011-06-23 Fmc Corporation Fine Particle Croscarmellose and Uses Thereof
NZ706991A (en) 2010-03-29 2016-08-26 Ferring Bv A fast dissolving pharmaceutical composition
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
JP2013526614A (ja) * 2010-05-25 2013-06-24 コサー，デイヴィッド 水銀毒性の低減のための組成物及び方法
RU2633640C2 (ru) 2011-09-16 2017-10-16 Ферринг Б.В. Быстрорастворимая фармацевтическая композиция
US8859005B2 (en) 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4311490A (en) * 1980-12-22 1982-01-19 General Electric Company Diamond and cubic boron nitride abrasive compacts using size selective abrasive particle layers
DE3275121D1 (en) * 1981-12-11 1987-02-19 Wyeth John & Brother Ltd Process for preparing solid shaped articles
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
DK0524180T3 (da) * 1990-04-11 1995-09-04 Upjohn Co Smagsmaskering af ibuprofen ved fluid bedovertrækning
JP2948317B2 (ja) * 1991-05-28 1999-09-13 マクニール―ピーピーシー・インコーポレーテツド 噛める薬物投与用組成物
JP2807346B2 (ja) * 1991-12-24 1998-10-08 山之内製薬株式会社 口腔内崩壊製剤及びその製造法
US5686107A (en) * 1995-01-30 1997-11-11 Fmc Corporation Chewable pharmaceutical tablets
ES2217410T3 (es) * 1996-04-16 2004-11-01 Novartis Consumer Health S.A. Forma de dosificacion oral de rapida desintegracion.
EP0839526A3 (en) * 1996-10-31 1999-01-07 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with fast buccal disintegration or dissolution
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
JPH11116466A (ja) * 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 急速溶解型固形製剤およびその製造法
US6194395B1 (en) * 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations

Also Published As

Publication number Publication date
CA2380449A1 (en) 2001-02-22
EP1202716A1 (en) 2002-05-08
US20020131998A1 (en) 2002-09-19
AU765526B2 (en) 2003-09-18
JP2003506480A (ja) 2003-02-18
HK1046236A1 (zh) 2003-01-03
US7182959B2 (en) 2007-02-27
AU7275700A (en) 2001-03-13
WO2001012161A1 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
TR200200313T2 (tr) Hızla çözünen dozaj formu ve bunun yapım prosesi.
EE200200487A (et) Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
SE0102438D0 (sv) New compounds
DE60045528D1 (de) Pharmazeutische zusammensetzungen, die ccr5-antagonisierende piperazinderivate enthalten
CY2016024I2 (el) ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
EE200100684A (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
ES2177346T3 (es) Formulaciones de ranolazina de liberacion lenta.
DZ3227A1 (fr) Compositions pharmaceutiques fournissant des concentrations de medicaments ameliorees
TR199802139T2 (xx) Sisaprid'in an�nda tahliye sa�layan, PH'dan ba��ms�z kat� dozaj �ekli.
HUP0300896A3 (en) Beta-amino acid nitrile derivatives, process for their preparation and pharmaceutical compositions containing them
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
DE60022188D1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
PA8579801A1 (es) Composiciones farmaceuticas de farmacos semiordenados y polimeros
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
FR2804024B1 (fr) Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation
ATE401060T1 (de) Schnell zerfallende tablette
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları
ATE344265T1 (de) Derivate von benzothiazin und benzothiadiazin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen diese enthaltend
ATE250578T1 (de) Indenoindolon-derivate, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen
FR2816841B1 (fr) Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
ATE321530T1 (de) Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure